Task: Answer the multiple choice question.
Query: Which drug exhibits a 1.468% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(OC(=O)/C=C/c1cccs1)C(=O)Nc1ccc(S(N)(=O)=O)cc1
b CCOc1ccc(CN(C)CC(O)COC(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1
Answer: a. CC(OC(=O)/C=C/c1cccs1)C(=O)Nc1ccc(S(N)(=O)=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(OC(=O)/C=C/c1cccs1)C(=O)Nc1ccc(S(N)(=O)=O)cc1
CC(OC(=O)/C=C/c1cccs1)C(=O)Nc1ccc(S(N)(=O)=O)cc1
[1-oxo-1-(4-sulfamoylanilino)propan-2-yl] (E)-3-thiophen-2-ylprop-2-enoate